Federico Perez
Federico Perez
Case Western Reserve University School of Medicine and Louis Stokes Cleveland VA Medical Center
Verified email at case.edu
Cited by
Cited by
Global challenge of multidrug-resistant Acinetobacter baumannii
F Perez, AM Hujer, KM Hujer, BK Decker, PN Rather, RA Bonomo
Antimicrobial agents and chemotherapy 51 (10), 3471-3484, 2007
The continuing challenge of ESBLs
F Perez, A Endimiani, KM Hujer, RA Bonomo
Current opinion in pharmacology 7 (5), 459-469, 2007
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective …
B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ...
The Lancet Infectious Diseases 17 (7), 726-734, 2017
Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae
D Van Duin, JJ Lok, M Earley, E Cober, SS Richter, F Perez, RA Salata, ...
Clinical Infectious Diseases 66 (2), 163-171, 2018
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
A Endimiani, AM Hujer, F Perez, CR Bethel, KM Hujer, J Kroeger, ...
Journal of Antimicrobial Chemotherapy 63 (3), 427-437, 2009
Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase: defining a unique family of class C enzymes
KM Hujer, NS Hamza, AM Hujer, F Perez, MS Helfand, CR Bethel, ...
Antimicrobial agents and chemotherapy 49 (7), 2941-2948, 2005
Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan
D Marchaim, T Chopra, JM Pogue, F Perez, AM Hujer, S Rudin, ...
Antimicrobial agents and chemotherapy 55 (2), 593-599, 2011
Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination
F Perez, A Endimiani, AJ Ray, BK Decker, CJ Wallace, KM Hujer, ...
Journal of Antimicrobial Chemotherapy 65 (8), 1807-1818, 2010
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
F Perez, D Van Duin
Cleveland Clinic journal of medicine 80 (4), 225, 2013
In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin
A Endimiani, G Patel, KM Hujer, M Swaminathan, F Perez, LB Rice, ...
Antimicrobial agents and chemotherapy 54 (1), 526-529, 2010
Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system
A Endimiani, JM DePasquale, S Forero, F Perez, AM Hujer, ...
Journal of antimicrobial chemotherapy 64 (5), 1102-1110, 2009
Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments
A Rodriguez Guardado, A Blanco, V Asensi, F Pérez, JC Rial, V Pintado, ...
Journal of Antimicrobial Chemotherapy 61 (4), 908-913, 2008
Can ceftazidime-avibactam and aztreonam overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae?
S Marshall, AM Hujer, LJ Rojas, KM Papp-Wallace, RM Humphries, ...
Antimicrobial agents and chemotherapy 61 (4), 2017
Intestinal carriage of carbapenemase-producing organisms: current status of surveillance methods
R Viau, KM Frank, MR Jacobs, B Wilson, K Kaye, CJ Donskey, F Perez, ...
Clinical microbiology reviews 29 (1), 1-27, 2016
Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship
D Marchaim, T Chopra, A Bhargava, C Bogan, S Dhar, K Hayakawa, ...
Infection control and hospital epidemiology 33 (8), 817, 2012
New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis
MS Wright, DH Haft, DM Harkins, F Perez, KM Hujer, S Bajaksouzian, ...
MBio 5 (1), 2014
Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy?
F Perez, NG El Chakhtoura, KM Papp-Wallace, BM Wilson, RA Bonomo
Expert opinion on pharmacotherapy 17 (6), 761-781, 2016
Prevalence and characterization of extended-spectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals
MV Villegas, A Correa, F Perez, MC Miranda, T Zuluaga, JP Quinn, ...
Diagnostic microbiology and infectious disease 49 (3), 217-222, 2004
Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network
D van Duin, F Perez, SD Rudin, E Cober, J Hanrahan, J Ziegler, ...
Antimicrobial agents and chemotherapy 58 (7), 4035-4041, 2014
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States
A Endimiani, LL Carias, AM Hujer, CR Bethel, KM Hujer, F Perez, ...
Antimicrobial agents and chemotherapy 52 (7), 2680-2682, 2008
The system can't perform the operation now. Try again later.
Articles 1–20